Liraglutide
STEP 8
Novo Nordisk · Phase 3 · Completed · Enrollment 338
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Semaglutide | Obesity or overweight | n/r | 68 | ITT | n/r |
| Placebo (semaglutide) | Obesity or overweight | n/r | 68 | n/r | n/r |
| Liraglutide | Obesity or overweight | n/r | 68 | ITT | n/r |
| Placebo (liraglutide) | Obesity or overweight | n/r | 68 | ITT | n/r |